Form 8-K - Current report:
SEC Accession No. 0001171843-17-006680
Filing Date
2017-11-07
Accepted
2017-11-07 08:01:27
Documents
2
Period of Report
2017-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_110617.htm 8-K 9450
2 PRESS RELEASE exh_991.htm EX-99.1 85692
  Complete submission text file 0001171843-17-006680.txt   96486
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 171181157
SIC: 2835 In Vitro & In Vivo Diagnostic Substances